The article presents the guidelines for the treatment of psoriasis in adults, non-small-cell lung cancer (NSCLC) and gastrointestinal stromal tumours (GISTs) from Great Britain National Institute for Health and Clinical Excellence (NICE). The use of ustekinumab is recommended if the person has ...
advanced squamous or non-squamous non-small-cell lung cancer, and an algorithm covering intrathoracic staging before radical treatment. Who is it for? Healthcare professionals Commissioners and providers People with lung cancer and their families and carers Lung cancer: diagnosis and management (NG122...
see NICE''s guidelines on cardiovascular disease: identifying and supporting people most at risk of dying early, type 1 diabetes in adults, asthma and chronic obstructive pulmonary disease) ? people with a smoking-related illness (see NICE''s guideline on lung cancer) Tobacco: preventing uptake,...
The aim of this study is to analyse the trends in technology appraisals for non-small cell lung cancer (NSCLC) treatments performed by the National Institute for Health and Care Excellence (NICE) over the last ten years.A systematic search was conducted for single technology appraisals of NSCLC...
脊柱是恶性肿瘤患者常见转移部位,肿瘤转移至脊柱后可导致疼痛、病理性骨折和神经压迫。为了优化脊柱转移瘤以及转移性脊髓压迫(metastatic spinal cord compression,MSCC)患者诊断和管理方法,2008年英国国家卫生与临床优化研究所(NICE)提出了首个英国关于MSCC患者(或存在MSCC风险)的诊疗指南。近年来,随着脊柱外科与放疗技术的...
Reports that the process used by Great Britain's National Institute for Clinical Excellence (NICE) to evaluate drugs in England and Wales has been hit with criticism over its decision on interferon beta as a treatment for multiple sclerosis. Accusations of being uncooperative, uncommunicative and bi...
Lung Cancer Treatment Option Infinal guidance, NICE recommended pembrolizumab (Keytruda, Merck, Sharp & Dohme), with pemetrexed (Alimta, Eli Lilly) and platinum chemotherapy, as a treatment option for some people with lung cancer. It said the treatment should be made available on England's Cancer...
The Limits of Surgical Treatment of Non-Small Cell Lung Cancer Summary: Between January 1, 1991 until December 31, 1996, 286 patients with non-small cell lung cancer were diagnosed and treated in the Department of Tube... J Skrickova,S Spelda,J Kaplanova - 《Acta Medica Austriaca》 被引...
In draft guidelines, the National Institute for Health and Care Excellence said it is not recommending third-line use of Imnovid in MM patients because Celgene failed to provide sufficient evidence of its effectiveness compared with current care. In other words, the drug did not offer “enough be...
see NICE''s guidelines on cardiovascular disease: identifying and supporting people most at risk of dying early, type 1 diabetes in adults, asthma and chronic obstructive pulmonary disease) ? people with a smoking-related illness (see NICE''s guideline on lung cancer) ...